Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lab-on-a-Chip Measures Mechanics of Bacteria Colonies

By LabMedica International staff writers
Posted on 06 Jul 2009
A microfluidic device, also known as a lab-on-a-chip, estimates biofilms resistance to pressure. More...
Biofilms experience various kinds of pressure in nature and in the body as they squeeze through capillaries and adhere to the surfaces of e.g., medical devices.

Most bacteria in nature form biofilms. Bacteria are single-celled organisms, but they rarely live alone, said John Younger, associate chair for research in the department of emergency medicine at the University of (U-M) Health System (UHMS; Ann Arbor, MI, USA). Prof. Younger is a coauthor of the study that forms the cover story of the July 7, 2009 edition of Langmuir.

To understand biofilms and their life cycle, it is necessary to consider their genetics as well as their mechanical properties. Biofilms are "materials that respond to forces, because how they live in the environment depends on that response," said Mike Solomon, associate professor of chemical engineering and macromolecular science and engineering, who is senior author of the paper.

The U-M microfluidic device provides the right scale. The channel-etched chip, made from a flexible polymer, allows scientists to study minute samples of between 50 and 500 bacterial cells that form biofilms of 10-50µ in size. Such small samples behave in the device as they do in the body. Tools that require larger samples do not always give an accurate picture of how a particular substance behaves on the smallest scales.

The biofilms studied had a greater elasticity than previous methods had measured. The scientists discovered a hardening response, which means that the more pressure applied to the biofilms, the more resistance the materials put forth.

Mechanical forces are set in motion when we defend ourselves against these bacterial colonies. Gene expression patterns can be studied indefinitely, but until it is known when the materials will bend or break and what the immune system has to do from a physical perspective, how to fight this opponent remains a mystery.

Experiments were performed on colonies of Staphylococcus epidermidis and Klebsiella pneumoniae, which are known to cause infections in hospitals. The new microfluidic device could also be used to measure the resistance of various other soft-solid materials in biomaterials, pharmaceutical fields, consumer products, and food science.

Related Links:
Department of Emergency Medicine at the University of Michigan Health System




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.